The CEOs of Anthropic, DeepMind, and OpenAI regularly single out drug discovery as the area where AI will have the greatest positive impact over the next decade. The first generation of AI drug ...
Instead of relying on trial-and-error and years of lab work, algorithms would scan huge datasets, design new molecules, and find treatments faster than ever before. Investors and pharmaceutical ...
Forbes contributors publish independent expert analyses and insights. Gaurav Sharma is a London-based analyst who covers energy & ESG. The concept of discovering new materials in laboratories for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback